These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21145329)

  • 1. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites.
    Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU
    Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.
    Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of selective GABA-A receptor subtypes in amelioration of cisplatin-induced neuropathic pain by 2'-chloro-6-methyl flavone (2'-Cl-6MF).
    Karim N; Khan I; Abdelhalim A; Halim SA; Khan A; Altaf N; Ahmad W; Ghaffar R; Al-Harrasi A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):929-940. PubMed ID: 33221972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics.
    Zeilhofer HU; Ralvenius WT; Acuña MA
    Adv Pharmacol; 2015; 73():71-96. PubMed ID: 25637438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
    Ralvenius WT; Acuña MA; Benke D; Matthey A; Daali Y; Rudolph U; Desmeules J; Zeilhofer HU; Besson M
    Neuropharmacology; 2016 Oct; 109():366-375. PubMed ID: 27392635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.
    Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU
    Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
    Knabl J; Zeilhofer UB; Crestani F; Rudolph U; Zeilhofer HU
    Pain; 2009 Feb; 141(3):233-238. PubMed ID: 19091469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of pathological pain through specific spinal GABAA receptor subtypes.
    Knabl J; Witschi R; Hösl K; Reinold H; Zeilhofer UB; Ahmadi S; Brockhaus J; Sergejeva M; Hess A; Brune K; Fritschy JM; Rudolph U; Möhler H; Zeilhofer HU
    Nature; 2008 Jan; 451(7176):330-4. PubMed ID: 18202657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents?
    Zeilhofer HU; Witschi R; Hösl K
    J Mol Med (Berl); 2009 May; 87(5):465-9. PubMed ID: 19259638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
    Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
    Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice.
    Jiang J; Shen YY; Li J; Lin YH; Luo CX; Zhu DY
    Eur J Pharmacol; 2015 Jun; 757():53-8. PubMed ID: 25835611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking spinal α2GABA
    Tudeau L; Acuña MA; Albisetti GW; Neumann E; Ralvenius WT; Scheurer L; Poe M; Cook JM; Johannssen HC; Zeilhofer HU
    Brain Res; 2020 Aug; 1741():146889. PubMed ID: 32439345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABA
    Neumann E; Ralvenius WT; Acuña MA; Rudolph U; Zeilhofer HU
    Neuropharmacology; 2018 Dec; 143():71-78. PubMed ID: 30240781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice.
    Asiedu MN; Mejia G; Ossipov MK; Malan TP; Kaila K; Price TJ
    J Pain; 2012 Jun; 13(6):546-54. PubMed ID: 22537560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.